APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gemcitabine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gemcitabine Industry Growth and Trends Forecast to 2032

22 December 2025109 pages

Choose your research edition.

Industry ResearchGemcitabine Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Gemcitabine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Gemcitabine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gemcitabine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Gemcitabine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Gemcitabine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gemcitabine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gemcitabine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gemcitabine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gemcitabine include Hisun Pharma, Pude Pharma, Qilu Pharma, Novartis, Mylan, Jari Pharma, Hansoh Pharma, Yibantian Pharma and HPGC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gemcitabine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gemcitabine market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gemcitabine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gemcitabine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gemcitabine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gemcitabine Market by Company

Hisun Pharma

Pude Pharma

Qilu Pharma

Novartis

Mylan

Jari Pharma

Hansoh Pharma

Yibantian Pharma

HPGC

Salius Pharma

Lilly France

Actavis

Accord Healthcare

Gemcitabine Segment by Type

1g/Vial

200mg/Vial

Gemcitabine Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Gemcitabine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gemcitabine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gemcitabine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gemcitabine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gemcitabine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gemcitabine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1g/Vial Table 2. Major Company of 200mg/Vial Table 3. Global Gemcitabine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Gemcitabine Sales by Type (2021-2026) & (kg) Table 5. Global Gemcitabine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Gemcitabine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Gemcitabine Sales Market Share in Value by Type (2021-2026) Table 8. Global Gemcitabine Price by Type (2021-2026) & (US$/kg) Table 9. Global Gemcitabine Sales by Type (2027-2032) & (kg) Table 10. Global Gemcitabine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Gemcitabine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Gemcitabine Sales Market Share in Value by Type (2027-2032) Table 13. Global Gemcitabine Price by Type (2027-2032) & (US$/kg) Table 14. North America Gemcitabine Sales by Type (2021-2026) & (kg) Table 15. North America Gemcitabine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Gemcitabine Sales by Type (2021-2026) & (kg) Table 17. Europe Gemcitabine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Gemcitabine Sales by Type (2021-2026) & (kg) Table 19. Asia-Pacific Gemcitabine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Gemcitabine Sales by Type (2021-2026) & (kg) Table 21. Latin America Gemcitabine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Gemcitabine Sales by Type (2021-2026) & (kg) Table 23. Middle East and Africa Gemcitabine Sales by Type (2021-2026) & (US$ Million) Table 24. Gemcitabine Industry Trends Table 25. Gemcitabine Industry Drivers Table 26. Gemcitabine Industry Opportunities and Challenges Table 27. Gemcitabine Industry Restraints Table 28. Global Gemcitabine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Gemcitabine Revenue Market Share by Company (2021-2026) Table 30. Global Gemcitabine Sales by Company (2021-2026) & (kg) Table 31. Global Gemcitabine Sales Share by Company (2021-2026) Table 32. Global Gemcitabine Market Price by Company (2021-2026) & (US$/kg) Table 33. Global Gemcitabine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Gemcitabine Major Company Production Sites and Headquarters Table 35. Global Gemcitabine Company, Product Type & Application Table 36. Global Gemcitabine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Gemcitabine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Gemcitabine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Gemcitabine Sales by Region (2021-2026) & (kg) Table 41. Global Gemcitabine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Gemcitabine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Gemcitabine Sales Market Share in Value by Region (2021-2026) Table 44. Global Gemcitabine Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 45. Global Gemcitabine Sales by Region (2027-2032) & (kg) Table 46. Global Gemcitabine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Gemcitabine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Gemcitabine Sales Market Share in Value by Region (2027-2032) Table 49. Global Gemcitabine Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 50. Global Gemcitabine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Gemcitabine Sales by Application (2021-2026) & (kg) Table 52. Global Gemcitabine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Gemcitabine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Gemcitabine Sales Market Share in Value by Application (2021-2026) Table 55. Global Gemcitabine Price by Application (2021-2026) & (US$/kg) Table 56. Global Gemcitabine Sales by Application (2027-2032) & (kg) Table 57. Global Gemcitabine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Gemcitabine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Gemcitabine Sales Market Share in Value by Application (2027-2032) Table 60. Global Gemcitabine Price by Application (2027-2032) & (US$/kg) Table 61. North America Gemcitabine Sales by Application (2021-2026) & (kg) Table 62. North America Gemcitabine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Gemcitabine Sales by Application (2021-2026) & (kg) Table 64. Europe Gemcitabine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Gemcitabine Sales by Application (2021-2026) & (kg) Table 66. Asia-Pacific Gemcitabine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Gemcitabine Sales by Application (2021-2026) & (kg) Table 68. Latin America Gemcitabine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Gemcitabine Sales by Application (2021-2026) & (kg) Table 70. Middle East and Africa Gemcitabine Sales by Application (2021-2026) & (US$ Million) Table 71. Hisun Pharma Company Information Table 72. Hisun Pharma Business Overview Table 73. Hisun Pharma Gemcitabine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Hisun Pharma Gemcitabine Product Portfolio Table 75. Hisun Pharma Recent Development Table 76. Pude Pharma Company Information Table 77. Pude Pharma Business Overview Table 78. Pude Pharma Gemcitabine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. Pude Pharma Gemcitabine Product Portfolio Table 80. Pude Pharma Recent Development Table 81. Qilu Pharma Company Information Table 82. Qilu Pharma Business Overview Table 83. Qilu Pharma Gemcitabine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. Qilu Pharma Gemcitabine Product Portfolio Table 85. Qilu Pharma Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Gemcitabine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. Novartis Gemcitabine Product Portfolio Table 90. Novartis Recent Development Table 91. Mylan Company Information Table 92. Mylan Business Overview Table 93. Mylan Gemcitabine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. Mylan Gemcitabine Product Portfolio Table 95. Mylan Recent Development Table 96. Jari Pharma Company Information Table 97. Jari Pharma Business Overview Table 98. Jari Pharma Gemcitabine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. Jari Pharma Gemcitabine Product Portfolio Table 100. Jari Pharma Recent Development Table 101. Hansoh Pharma Company Information Table 102. Hansoh Pharma Business Overview Table 103. Hansoh Pharma Gemcitabine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. Hansoh Pharma Gemcitabine Product Portfolio Table 105. Hansoh Pharma Recent Development Table 106. Yibantian Pharma Company Information Table 107. Yibantian Pharma Business Overview Table 108. Yibantian Pharma Gemcitabine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 109. Yibantian Pharma Gemcitabine Product Portfolio Table 110. Yibantian Pharma Recent Development Table 111. HPGC Company Information Table 112. HPGC Business Overview Table 113. HPGC Gemcitabine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 114. HPGC Gemcitabine Product Portfolio Table 115. HPGC Recent Development Table 116. Salius Pharma Company Information Table 117. Salius Pharma Business Overview Table 118. Salius Pharma Gemcitabine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 119. Salius Pharma Gemcitabine Product Portfolio Table 120. Salius Pharma Recent Development Table 121. Lilly France Company Information Table 122. Lilly France Business Overview Table 123. Lilly France Gemcitabine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 124. Lilly France Gemcitabine Product Portfolio Table 125. Lilly France Recent Development Table 126. Actavis Company Information Table 127. Actavis Business Overview Table 128. Actavis Gemcitabine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 129. Actavis Gemcitabine Product Portfolio Table 130. Actavis Recent Development Table 131. Accord Healthcare Company Information Table 132. Accord Healthcare Business Overview Table 133. Accord Healthcare Gemcitabine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 134. Accord Healthcare Gemcitabine Product Portfolio Table 135. Accord Healthcare Recent Development Table 136. North America Gemcitabine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 137. North America Gemcitabine Sales by Country (2021-2026) & (kg) Table 138. North America Gemcitabine Sales Market Share by Country (2021-2026) Table 139. North America Gemcitabine Sales Forecast by Country (2027-2032) & (kg) Table 140. North America Gemcitabine Sales Market Share Forecast by Country (2027-2032) Table 141. North America Gemcitabine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Gemcitabine Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Gemcitabine Market Share by Country (2021-2026) Table 144. North America Gemcitabine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Gemcitabine Market Share Forecast by Country (2027-2032) Table 146. Europe Gemcitabine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 147. Europe Gemcitabine Sales by Country (2021-2026) & (kg) Table 148. Europe Gemcitabine Sales Market Share by Country (2021-2026) Table 149. Europe Gemcitabine Sales Forecast by Country (2027-2032) & (kg) Table 150. Europe Gemcitabine Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Gemcitabine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Gemcitabine Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Gemcitabine Market Share by Country (2021-2026) Table 154. Europe Gemcitabine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Gemcitabine Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Gemcitabine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Gemcitabine Sales by Country (2021-2026) & (kg) Table 158. Asia-Pacific Gemcitabine Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Gemcitabine Sales Forecast by Country (2027-2032) & (kg) Table 160. Asia-Pacific Gemcitabine Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Gemcitabine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Gemcitabine Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Gemcitabine Market Share by Country (2021-2026) Table 164. Asia-Pacific Gemcitabine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Gemcitabine Market Share Forecast by Country (2027-2032) Table 166. Latin America Gemcitabine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 167. Latin America Gemcitabine Sales by Country (2021-2026) & (kg) Table 168. Latin America Gemcitabine Sales Market Share by Country (2021-2026) Table 169. Latin America Gemcitabine Sales Forecast by Country (2027-2032) & (kg) Table 170. Latin America Gemcitabine Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Gemcitabine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Gemcitabine Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Gemcitabine Market Share by Country (2021-2026) Table 174. Latin America Gemcitabine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Gemcitabine Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Gemcitabine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Gemcitabine Sales by Country (2021-2026) & (kg) Table 178. Middle East and Africa Gemcitabine Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Gemcitabine Sales Forecast by Country (2027-2032) & (kg) Table 180. Middle East and Africa Gemcitabine Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Gemcitabine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Gemcitabine Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Gemcitabine Market Share by Country (2021-2026) Table 184. Middle East and Africa Gemcitabine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Gemcitabine Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Gemcitabine Distributors List Table 189. Gemcitabine Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Gemcitabine Image Figure 2. Global Gemcitabine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gemcitabine Market Size (2021-2032) & (US$ Million) Figure 4. Global Gemcitabine Sales (2021-2032) & (kg) Figure 5. 1g/Vial Image Figure 6. Global 1g/Vial Sales YoY Growth (2021-2032) & (kg) Figure 7. 200mg/Vial Image Figure 8. Global 200mg/Vial Sales YoY Growth (2021-2032) & (kg) Figure 9. Global Gemcitabine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Gemcitabine Market Share by Type 2025 VS 2032 Figure 11. North America Gemcitabine Sales Market Share in Volume by Type in 2025 Figure 12. North America Gemcitabine Sales Market Share in Value by Type in 2025 Figure 13. Europe Gemcitabine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Gemcitabine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Gemcitabine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Gemcitabine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Gemcitabine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Gemcitabine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Gemcitabine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Gemcitabine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Gemcitabine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Pharmacies Image Figure 24. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 25. Online Pharmacies Image Figure 26. Global Online Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 27. Retail Pharmacies Image Figure 28. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 29. Global Gemcitabine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Gemcitabine Market Share by Application 2025 VS 2032 Figure 31. North America Gemcitabine Sales Market Share in Volume by Application in 2025 Figure 32. North America Gemcitabine Sales Market Share in Value by Application in 2025 Figure 33. Europe Gemcitabine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Gemcitabine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Gemcitabine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Gemcitabine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Gemcitabine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Gemcitabine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Gemcitabine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Gemcitabine Sales Market Share in Value by Application in 2025 Figure 41. North America Gemcitabine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 42. North America Gemcitabine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Gemcitabine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Gemcitabine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Gemcitabine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 46. Europe Gemcitabine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Gemcitabine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Gemcitabine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Gemcitabine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 50. Asia-Pacific Gemcitabine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Gemcitabine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Gemcitabine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Gemcitabine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 54. Latin America Gemcitabine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Gemcitabine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Gemcitabine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Gemcitabine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 58. Middle East and Africa Gemcitabine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Gemcitabine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Gemcitabine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Gemcitabine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Gemcitabine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 1g/Vial
  • 200mg/Vial
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Hisun Pharma
  • Pude Pharma
  • Qilu Pharma
  • Novartis
  • Mylan
  • Jari Pharma
  • Hansoh Pharma
  • Yibantian Pharma
  • HPGC
  • Salius Pharma
  • Lilly France
  • Actavis
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gemcitabine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gemcitabine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gemcitabine Market by Type
  6. 1.3.1 1g/Vial
  7. 1.3.2 200mg/Vial
  8. 1.4 Global Gemcitabine Market Size by Type
  9. 1.4.1 Global Gemcitabine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Gemcitabine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Gemcitabine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Gemcitabine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Gemcitabine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Gemcitabine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Gemcitabine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Gemcitabine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gemcitabine Industry Trends
  2. 2.2 Gemcitabine Industry Drivers
  3. 2.3 Gemcitabine Industry Opportunities and Challenges
  4. 2.4 Gemcitabine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gemcitabine Revenue (2021-2026)
  2. 3.2 Global Top Players by Gemcitabine Sales (2021-2026)
  3. 3.3 Global Top Players by Gemcitabine Price (2021-2026)
  4. 3.4 Global Gemcitabine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gemcitabine Major Company Production Sites & Headquarters
  6. 3.6 Global Gemcitabine Company, Product Type & Application
  7. 3.7 Global Gemcitabine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gemcitabine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gemcitabine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gemcitabine Tier 1, Tier 2, and Tier 3
4 Gemcitabine Regional Status and Outlook
  1. 4.1 Global Gemcitabine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gemcitabine Historic Market Size by Region
  3. 4.2.1 Global Gemcitabine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gemcitabine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gemcitabine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gemcitabine Forecasted Market Size by Region
  7. 4.3.1 Global Gemcitabine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gemcitabine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gemcitabine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gemcitabine by Application
  1. 5.1 Gemcitabine Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Gemcitabine Market Size by Application
  6. 5.2.1 Global Gemcitabine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Gemcitabine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Gemcitabine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Gemcitabine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Gemcitabine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Gemcitabine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Gemcitabine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Gemcitabine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hisun Pharma
  2. 6.1.1 Hisun Pharma Company Information
  3. 6.1.2 Hisun Pharma Business Overview
  4. 6.1.3 Hisun Pharma Gemcitabine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hisun Pharma Gemcitabine Product Portfolio
  6. 6.1.5 Hisun Pharma Recent Developments
  7. 6.2 Pude Pharma
  8. 6.2.1 Pude Pharma Company Information
  9. 6.2.2 Pude Pharma Business Overview
  10. 6.2.3 Pude Pharma Gemcitabine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pude Pharma Gemcitabine Product Portfolio
  12. 6.2.5 Pude Pharma Recent Developments
  13. 6.3 Qilu Pharma
  14. 6.3.1 Qilu Pharma Company Information
  15. 6.3.2 Qilu Pharma Business Overview
  16. 6.3.3 Qilu Pharma Gemcitabine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qilu Pharma Gemcitabine Product Portfolio
  18. 6.3.5 Qilu Pharma Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Gemcitabine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Gemcitabine Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Gemcitabine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Gemcitabine Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 Jari Pharma
  32. 6.6.1 Jari Pharma Company Information
  33. 6.6.2 Jari Pharma Business Overview
  34. 6.6.3 Jari Pharma Gemcitabine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jari Pharma Gemcitabine Product Portfolio
  36. 6.6.5 Jari Pharma Recent Developments
  37. 6.7 Hansoh Pharma
  38. 6.7.1 Hansoh Pharma Company Information
  39. 6.7.2 Hansoh Pharma Business Overview
  40. 6.7.3 Hansoh Pharma Gemcitabine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hansoh Pharma Gemcitabine Product Portfolio
  42. 6.7.5 Hansoh Pharma Recent Developments
  43. 6.8 Yibantian Pharma
  44. 6.8.1 Yibantian Pharma Company Information
  45. 6.8.2 Yibantian Pharma Business Overview
  46. 6.8.3 Yibantian Pharma Gemcitabine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Yibantian Pharma Gemcitabine Product Portfolio
  48. 6.8.5 Yibantian Pharma Recent Developments
  49. 6.9 HPGC
  50. 6.9.1 HPGC Company Information
  51. 6.9.2 HPGC Business Overview
  52. 6.9.3 HPGC Gemcitabine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 HPGC Gemcitabine Product Portfolio
  54. 6.9.5 HPGC Recent Developments
  55. 6.10 Salius Pharma
  56. 6.10.1 Salius Pharma Company Information
  57. 6.10.2 Salius Pharma Business Overview
  58. 6.10.3 Salius Pharma Gemcitabine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Salius Pharma Gemcitabine Product Portfolio
  60. 6.10.5 Salius Pharma Recent Developments
  61. 6.11 Lilly France
  62. 6.11.1 Lilly France Company Information
  63. 6.11.2 Lilly France Business Overview
  64. 6.11.3 Lilly France Gemcitabine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Lilly France Gemcitabine Product Portfolio
  66. 6.11.5 Lilly France Recent Developments
  67. 6.12 Actavis
  68. 6.12.1 Actavis Company Information
  69. 6.12.2 Actavis Business Overview
  70. 6.12.3 Actavis Gemcitabine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Actavis Gemcitabine Product Portfolio
  72. 6.12.5 Actavis Recent Developments
  73. 6.13 Accord Healthcare
  74. 6.13.1 Accord Healthcare Company Information
  75. 6.13.2 Accord Healthcare Business Overview
  76. 6.13.3 Accord Healthcare Gemcitabine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Accord Healthcare Gemcitabine Product Portfolio
  78. 6.13.5 Accord Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Gemcitabine Sales by Country
  2. 7.1.1 North America Gemcitabine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gemcitabine Sales by Country (2021-2026)
  4. 7.1.3 North America Gemcitabine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gemcitabine Market Size by Country
  6. 7.2.1 North America Gemcitabine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gemcitabine Market Size by Country (2021-2026)
  8. 7.2.3 North America Gemcitabine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gemcitabine Sales by Country
  2. 8.1.1 Europe Gemcitabine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gemcitabine Sales by Country (2021-2026)
  4. 8.1.3 Europe Gemcitabine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gemcitabine Market Size by Country
  6. 8.2.1 Europe Gemcitabine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gemcitabine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gemcitabine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gemcitabine Sales by Country
  2. 9.1.1 Asia-Pacific Gemcitabine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gemcitabine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gemcitabine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gemcitabine Market Size by Country
  6. 9.2.1 Asia-Pacific Gemcitabine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gemcitabine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gemcitabine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gemcitabine Sales by Country
  2. 10.1.1 South America Gemcitabine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gemcitabine Sales by Country (2021-2026)
  4. 10.1.3 South America Gemcitabine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gemcitabine Market Size by Country
  6. 10.2.1 South America Gemcitabine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gemcitabine Market Size by Country (2021-2026)
  8. 10.2.3 South America Gemcitabine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gemcitabine Sales by Country
  2. 11.1.1 Middle East and Africa Gemcitabine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gemcitabine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gemcitabine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gemcitabine Market Size by Country
  6. 11.2.1 Middle East and Africa Gemcitabine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gemcitabine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gemcitabine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gemcitabine Value Chain Analysis
  2. 12.1.1 Gemcitabine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gemcitabine Production Mode & Process
  7. 12.2 Gemcitabine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gemcitabine Distributors
  10. 12.2.3 Gemcitabine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst